C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade
Brian Casserly
, Jeffrey M. Mazer
, Alexander Vang
, Elizabeth O. Harrington
, James R. Klinger
, Sharon Rounds
, Gaurav Choudhary
Brown University
VA Medical Center
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'C-type natriuretic peptide does not attenuate the development of pulmonary hypertension caused by hypoxia and VEGF receptor blockade'. Together they form a unique fingerprint.
Medicine and Dentistry
Pharmacology, Toxicology and Pharmaceutical Science